Invesco Ltd. Intra Cellular Therapies, Inc. Transaction History

Invesco Ltd.

$516 Billion
Q4 2024

A detailed history of Invesco Ltd. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 3,077,174 shares of ITCI stock, worth $394 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,077,174

Previous 2,989,592 2.93%

Holding current value

$394 Million

Previous $219 Million 17.57%

% of portfolio

0.05%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$71.19 - $91.57 $6.23 Million - $8.02 Million	87,582 Added 2.93%	3,077,174 $257 Million
Q3 2024 Nov 12, 2024	BUY	$67.99 - $80.84 $3.55 Million - $4.22 Million	52,238 Added 1.78%	2,989,592 $219 Million
Q2 2024 Aug 13, 2024	BUY	$64.76 - $79.84 $56 Million - $69 Million	864,373 Added 41.7%	2,937,354 $201 Million
Q1 2024 May 14, 2024	BUY	$64.37 - $75.65 $7.04 Million - $8.27 Million	109,324 Added 5.57%	2,072,981 $143 Million
Q4 2023 Feb 12, 2024	BUY	$46.37 - $73.65 $1.31 Million - $2.08 Million	28,275 Added 1.46%	1,963,657 $141 Million
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $2.06 Million - $2.53 Million	-39,499 Reduced 2.0%	1,935,382 $101 Million
Q2 2023 Aug 11, 2023	BUY	$54.67 - $66.44 $8.53 Million - $10.4 Million	156,089 Added 8.58%	1,974,881 $125 Million
Q1 2023 May 12, 2023	BUY	$43.8 - $56.99 $1.87 Million - $2.44 Million	42,761 Added 2.41%	1,818,792 $98.5 Million
Q4 2022 Feb 13, 2023	BUY	$44.07 - $54.45 $4.11 Million - $5.08 Million	93,238 Added 5.54%	1,776,031 $94 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $37 Million - $52 Million	866,606 Added 106.18%	1,682,793 $78.3 Million
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $14.5 Million - $22.2 Million	337,802 Added 70.61%	816,187 $46.6 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $17.3 Million - $27.7 Million	445,945 Added 1374.68%	478,385 $29.3 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $61,846 - $93,858	-1,757 Reduced 5.14%	32,440 $1.7 Million
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $6.3 Million - $9.33 Million	-219,481 Reduced 86.52%	34,197 $1.28 Million
Q2 2021 Aug 17, 2021	SELL	$29.3 - $44.5 $1.45 Million - $2.2 Million	-49,496 Reduced 16.33%	253,678 $10.4 Million
Q1 2021 May 17, 2021	BUY	$30.8 - $39.51 $8.65 Million - $11.1 Million	280,800 Added 1255.03%	303,174 $10.3 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $5.55 Million - $7.67 Million	-237,998 Reduced 91.41%	22,374 $712,000
Q3 2020 Nov 16, 2020	SELL	$17.61 - $31.86 $33,494 - $60,597	-1,902 Reduced 0.73%	260,372 $6.68 Million
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $448,652 - $832,899	-31,265 Reduced 10.65%	262,274 $6.73 Million
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $3.23 Million - $8.68 Million	261,986 Added 830.3%	293,539 $4.51 Million
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $25,351 - $134,407	-3,492 Reduced 9.96%	31,553 $1.08 Million
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $9,591 - $18,014	1,284 Added 3.8%	35,045 $261,000
Q2 2019 Aug 14, 2019	BUY	$10.65 - $14.29 $21,939 - $29,437	2,060 Added 6.5%	33,761 $438,000
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $133,219 - $172,207	12,222 Added 62.74%	31,701 $386,000
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $201,802 - $408,279	19,479 New	19,479 $222,000

Others Institutions Holding ITCI

# of Institutions

415

Shares Held

88.5M

Call Options Held

284K

Put Options Held

105K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.1B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account